Form 4: Gilead Sciences EVP Deborah Telman Reports Stock Transactions
SEC Form 4 Filing
Deborah H. Telman, EVP of Corporate Affairs & GC at Gilead Sciences, reports the vesting and subsequent sale of restricted stock units.
Summary
- On October 25, 2024, Deborah H. Telman, EVP, Corporate Affairs & GC of Gilead Sciences, Inc., reported transactions involving common stock and restricted stock units.
- Telman exercised 514 restricted stock units, which converted into 514 shares of common stock.
- Simultaneously, Telman disposed of 242 shares of common stock at a price of $89.
- Following these transactions, Telman directly owns 20,979 shares of Gilead Sciences common stock and 29,033 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock transactions by an executive.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is closely monitored by investors for signals about the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but it's unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 10/25/2024 | Date of stock transactions (exercise of restricted stock units and sale of shares). |
| 10/28/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.